Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($) $ in Thousands	ATM Offering [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	ATM Offering [Member] Common Stock [Member] Series A Preferred Stock [Member]	ATM Offering [Member] Common Stock [Member]	ATM Offering [Member] Additional Paid-in Capital [Member]	ATM Offering [Member] Retained Earnings [Member]	ATM Offering [Member] AOCI Attributable to Parent [Member]	ATM Offering [Member]	Registered Direct Offering [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Registered Direct Offering [Member] Common Stock [Member] Series A Preferred Stock [Member]	Registered Direct Offering [Member] Common Stock [Member]	Registered Direct Offering [Member] Additional Paid-in Capital [Member]	Registered Direct Offering [Member] Retained Earnings [Member]	Registered Direct Offering [Member] AOCI Attributable to Parent [Member]	Registered Direct Offering [Member]	Common Stock and Warrant Issuance [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock and Warrant Issuance [Member] Common Stock [Member] Series A Preferred Stock [Member]	Common Stock and Warrant Issuance [Member] Common Stock [Member]	Common Stock and Warrant Issuance [Member] Additional Paid-in Capital [Member]	Common Stock and Warrant Issuance [Member] Retained Earnings [Member]	Common Stock and Warrant Issuance [Member] AOCI Attributable to Parent [Member]	Common Stock and Warrant Issuance [Member]	Consideration Shares [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Consideration Shares [Member] Common Stock [Member] Series A Preferred Stock [Member]	Consideration Shares [Member] Common Stock [Member]	Consideration Shares [Member] Additional Paid-in Capital [Member]	Consideration Shares [Member] Retained Earnings [Member]	Consideration Shares [Member] AOCI Attributable to Parent [Member]	Consideration Shares [Member]	Private Placement [Member] Preferred Stock [Member] Series A Preferred Stock [Member]	Private Placement [Member] Common Stock [Member] Series A Preferred Stock [Member]	Private Placement [Member] Common Stock [Member]	Private Placement [Member] Additional Paid-in Capital [Member]	Private Placement [Member] Retained Earnings [Member]	Private Placement [Member] AOCI Attributable to Parent [Member]	Private Placement [Member]	Warrants Issued for Alvogen Agreement Amendment [Member] Common Stock [Member] Series A Preferred Stock [Member]	Warrants Issued for Alvogen Agreement Amendment [Member] Common Stock [Member]	Warrants Issued for Alvogen Agreement Amendment [Member] Additional Paid-in Capital [Member]	Warrants Issued for Alvogen Agreement Amendment [Member] Retained Earnings [Member]	Warrants Issued for Alvogen Agreement Amendment [Member] AOCI Attributable to Parent [Member]	Warrants Issued for Alvogen Agreement Amendment [Member]	Preferred Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member] Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Dec. 31, 2023																																										3,000,000		8,391,940
Balance at Dec. 31, 2023																																											$ 3	$ 8	$ 241,406	$ (253,147)	$ (3)	$ (11,733)
Stock-based compensation																																											0	$ 0	242	0	0	242
Shares issued as repayment of principal and interest for convertible note (in shares)																																										0		143,648
Shares issued as repayment of principal and interest for convertible note																																											0	$ 1	399	0	0	400
Shares issued during period (in shares)	0		34,584												0		575,000												0		270,000
Shares issued during period		$ 0	$ 0	$ 179	$ 0	$ 0	$ 179									$ 0	$ 1	$ 1,343	$ 0	$ 0	$ 1,344									$ 0	$ 0	$ 1,027	$ 0	$ 0	$ 1,027
Fair Value of warrants issued with registered direct offering																																				$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Net loss																																											0	$ 0	0	(6,528)	0	(6,528)
Balance (in shares) at Mar. 31, 2024																																										0		9,772,672
Balance at Mar. 31, 2024																																											0	$ 10	244,599	(259,675)	(3)	(15,069)
Conversion of Series A preferred stock into common stock (in shares)																																										(3,000,000)		300,000
Conversion of Series A preferred stock into common stock																																											(3)	$ 0	3	0	0	0
Vesting of restricted stock awards (in shares)																																										0		57,500
Vesting of restricted stock awards																																											0	$ 0	0	0	0	0
Balance (in shares) at Dec. 31, 2023																																										3,000,000		8,391,940
Balance at Dec. 31, 2023																																											3	$ 8	241,406	(253,147)	(3)	(11,733)
Net loss																																																(16,048)
Balance (in shares) at Sep. 30, 2024																																										0		11,373,246
Balance at Sep. 30, 2024																																											0	$ 11	250,362	(269,195)	0	(18,822)
Balance (in shares) at Mar. 31, 2024																																										0		9,772,672
Balance at Mar. 31, 2024																																											0	$ 10	244,599	(259,675)	(3)	(15,069)
Stock-based compensation																																											0	0	97	0	0	97
Shares issued during period (in shares)	0		247,868												0		698,050
Shares issued during period		0	$ 0	1,228	0	0	1,228									$ 0	$ 1	$ 1,913	$ 0	$ 0	$ 1,914
Net loss																																											0	$ 0	0	(7,897)	0	(7,897)
Balance (in shares) at Jun. 30, 2024																																										0		10,791,630
Balance at Jun. 30, 2024																																											0	$ 11	249,173	(267,572)	(3)	(18,391)
Issuance of shares related to reverse stock split (in shares)																																										0
Contract cost related to Alvogen termination (see Note 9)																																											0	0	1,336	0	0	1,336
Stock-based compensation																																											0	$ 0	104	0	0	104
Shares issued as repayment of principal and interest for convertible note (in shares)																																										0		458,553
Shares issued as repayment of principal and interest for convertible note																																											0	$ 0	829	0	0	829
Shares issued during period (in shares)	0		103,063
Shares issued during period		0	$ 0	219	0	0	$ 219
Net loss																																											0	$ 0	0	(1,623)	0	(1,623)
Common Stock issued in exchange for services (in shares)																																										0		20,000
Common Stock issued in exchange for services																																											0	$ 0	(37)	0	0	(37)
Common Stock issued in exchange for services																																											0	$ 0	37	0	0	37
Balance (in shares) at Sep. 30, 2024																																										0		11,373,246
Balance at Sep. 30, 2024																																											0	$ 11	250,362	(269,195)	0	(18,822)
Reclassification of AOCI upon settlement of Streeterville Note																																											0	$ 0	0	0	3	3
Balance (in shares) at Dec. 31, 2024																																										0		14,591,505
Balance at Dec. 31, 2024																																											0	$ 15	255,035	(278,273)	0	(23,223)
Stock-based compensation																																											0	$ 0	12	0	0	12
Shares issued as repayment of principal and interest for convertible note (in shares)																																										0		1,009,518
Shares issued as repayment of principal and interest for convertible note																																											0	$ 1	2,939	0	0	2,940
Shares issued during period (in shares)								0		1,215,278
Shares issued during period									$ 0	$ 1	$ 3,254	$ 0	$ 0	$ 3,255
Fair Value of warrants issued with registered direct offering																																											0	0	(3,255)	0	0	(3,255)
Amortization of prepaid offering costs																																											0	0	(7)	0	0	(7)
Shares issued as a result of repricing under VWAP (in shares)																						0		303,819
Shares issued as a result of repricing under VWAP																							$ 0	$ 0	$ 629	$ 0	$ 0	$ 629
Net loss																																											0	$ 0	0	(5,512)	0	(5,512)
Balance (in shares) at Mar. 31, 2025																																										0		7,120,120
Balance at Mar. 31, 2025																																											0	$ 17	258,607	(283,785)	0	(25,161)
Balance (in shares) at Dec. 31, 2024																																										0		14,591,505
Balance at Dec. 31, 2024																																											0	$ 15	255,035	(278,273)	0	(23,223)
Shares issued during period (in shares)							1,749,866
Shares issued during period							$ 4,700
Net loss																																																(28,982)
Balance (in shares) at Sep. 30, 2025																																										0		27,682,530
Balance at Sep. 30, 2025																																											0	$ 28	281,473	(307,256)	0	(25,755)
Balance (in shares) at Mar. 31, 2025																																										0		7,120,120
Balance at Mar. 31, 2025																																											0	$ 17	258,607	(283,785)	0	(25,161)
Stock-based compensation																																											0	$ 0	67	0	0	67
Shares issued as repayment of principal and interest for convertible note (in shares)																																										0		1,879,406
Shares issued as repayment of principal and interest for convertible note																																											0	$ 2	5,981	0	0	5,983
Shares issued during period (in shares)	0		399,078
Shares issued during period		0	$ 0	1,012	0	0	$ 1,012
Amortization of prepaid offering costs																																											0	0	(85)	0	0	(85)
Net loss																																											0	$ 0	0	(17,581)	0	(17,581)
Common Stock issued in exchange for services (in shares)																																										0		75,000
Common Stock issued in exchange for services																																											0	$ 0	(150)	0	0	(150)
Common Stock issued in exchange for services																																											0	$ 0	150	0	0	150
Balance (in shares) at Jun. 30, 2025																																										0		19,473,588
Balance at Jun. 30, 2025																																											0	$ 19	265,732	(301,366)	0	(35,615)
Stock-based compensation																																											0	$ 0	68	0	0	68
Shares issued as repayment of principal and interest for convertible note (in shares)																																										0		877,193
Shares issued as repayment of principal and interest for convertible note																																											0	$ 1	2,218	0	0	2,219
Shares issued during period (in shares)	0		1,350,788				1,350,788																																			0		3,959,999
Shares issued during period		$ 0	$ 1	$ 3,739	$ 0	$ 0	$ 3,740																																				0	$ 4	6,209	0	0	6,213
Amortization of prepaid offering costs																																											0	0	(28)	0	0	(28)
Net loss																																											0	$ 0	0	(5,890)	0	(5,890)
Common Stock issued in exchange for services (in shares)																																										0		150,000
Common Stock issued in exchange for services																																											0	$ (1)	(450)	0	0	(451)
Common Stock issued as a result of exercise of warrants (in shares)																																												1,870,962
Common Stock issued as a result of exercise of warrants																																												$ 2	3,085			3,087
Common Stock issued in exchange for services																																											0	$ 1	450	0	0	451
Balance (in shares) at Sep. 30, 2025																																										0		27,682,530
Balance at Sep. 30, 2025																																											$ 0	$ 28	$ 281,473	$ (307,256)	$ 0	$ (25,755)